NYSE: XRNChiron Real Estate Inc Stock
$37.20+0.96 (+2.65%)
Updated Feb 25, 2026
XRN Price
$37.20
Fair Value Price
N/A
Market Cap
$498.75M
52 Week Low
$29.05
52 Week High
$45.75
P/E
-148.8x
P/B
1.03x
P/S
3.11x
PEG
N/A
Dividend Yield
8.87%
Revenue
$144.97M
Earnings
$2.50M
Gross Margin
100%
Operating Margin
23.05%
Profit Margin
-2.3%
Debt to Equity
1.58
Operating Cash Flow
$73M
Beta
0.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
XRN Overview
Global Medical REIT Inc. leases purpose-built healthcare facilities in select markets to clinical operators with dominant market share. Its facilities include surgery centers, specialty hospitals, and outpatient treatment centers. Global Medical REIT was founded in 2011 and is headquartered in Bethesda, MD.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XRN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
XRN
Ranked#12 of 17
Ranked#12 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $16.82 | B | |
| $12.96 | B | |
| $52.92 | C |
Be the first to know about important XRN news, forecast changes, insider trades & much more!
XRN News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XRN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XRN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XRN is good value based on its book value relative to its share price (1.03x), compared to the US REIT - Healthcare Facilities industry average (2.77x)
P/B vs Industry Valuation
XRN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more XRN due diligence checks available for Premium users.
Valuation
XRN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-148.8x
Industry
136.62x
Market
40.72x
XRN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.03x
Industry
2.77x
XRN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XRN's financial health
Profit margin
Revenue
$37.2M
Net Income
-$4.5M
Profit Margin
-16.1%
XRN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3B
Liabilities
$767.4M
Debt to equity
1.58
XRN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
XRN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$17.6M
Investing
-$703.0k
Financing
-$16.2M
XRN vs Healthcare Facility REIT Stocks
Chiron Real Estate Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.